The GFPT2 gene that encodes the first and rate-limiting enzyme in HBP, was the top enriched gene in the datasets of Chudasama et al., Beck et al., and in the recurrent and metastatic tumors in our dataset of 70 LMS (Supplementary Tables 5–7). The gene discussed is GFPT2; the disease is metastatic neoplasm.